Background illustration for clinical trials search

Paid Clinical Trials Alberta

Discover 818 paid clinical trials in Alberta . Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Feasibility and Acceptability of Collecting Sociodemographic Data in CCTG Trials

for
Cancer
Location: Saint John, Quebec, Ottawa, Kingston, Toronto, Hamilton,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT07390435

Recruiting

Therapeutic Cuddling in Critically Ill Children

for
Pain, Delirium in the Intensive Care Unit
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 0 - 18

Code: NCT07562048

Recruiting

Impact of a Mandibular Oral Repositioning Device on Sleep Quality, Heart Rate Variability, & SpO2

for
Sleep
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 40 - 65

Code: NCT07359638

Recruiting

Cannabis for the Prophylactic Treatment of Migraine

for
Chronic Migraine
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 25+

Code: NCT03972124

Phase 2, Recruiting

Sleep Quality in Assisted-Living Residents

for
Sleep Disturbance, Aging
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 50+

Code: NCT04400617

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

for
Relapsed AL Amyloidosis, Refractory AL Amyloidosis,
Location: Boston MA, New York NY, Toronto, Tampa FL, Cleveland OH,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07081646

Phase 1, Phase 2, Recruiting

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

for
KRAS Altered Advanced or Metastatic Solid Tumors
Location: Boston MA, Montreal, Philadelphia PA, Fairfax VA,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT07094113

Phase 1, Recruiting

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

for
Colitis Ulcerative, Ulcerative Colitis
Location: Montreal, Miami FL, Toronto, Orlando FL, Inverness FL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70+

Code: NCT07463183

Phase 2, Recruiting

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

for
Plaque Psoriasis
Location: St. John's, Milford MA, Robbinsville NJ,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 12 - 17

Code: NCT06979453

Phase 3, Recruiting

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

for
Alopecia Areata
Location: Verona NJ, Plymouth Meeting PA, Rockville MD, Cary NC,
Sponsor: Sun Pharmaceutical Industries, Inc.

Sex: All

Age: 12 - 17

Code: NCT07133308

Phase 3, Recruiting

Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass

for
Type 2 Diabetes, Obesity, Semaglutide, GLP-1, Diabetes
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18 - 70+

Code: NCT07272837

Recruiting

Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study

for
Cardiac Arrest, COVID-19, Coronavirus
Location: Toronto, Calgary, Los Angeles CA
Sponsor: KidSIM Simulation Program

Sex: All

Age: 18 - 60

Code: NCT05868239

Recruiting

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

for
Multiple Myeloma
Location: Halifax, Commack NY, Uniondale NY, Harrison NY,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT05020236

Phase 3, Recruiting

AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF

for
Idiopathic Pulmonary Fibrosis (IPF)
Location: St. John's, Halifax, Sherbrooke, Trois-Rivieres,
Sponsor: Avalyn Pharma Inc.

Sex: All

Age: 40+

Code: NCT07194382

Phase 2, Recruiting

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.

for
Invasive Mold Infections
Location: New York NY, Philadelphia PA, Baltimore MD, Ottawa,
Sponsor: Basilea Pharmaceutica

Sex: All

Age: 18+

Code: NCT06925321

Phase 3, Recruiting

A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

for
Palmoplantar Pustulosis
Location: Fredericton, Elmhurst NY, Philadelphia PA, Hamilton,
Sponsor: LEO Pharma

Sex: All

Age: 18+

Code: NCT07013201

Phase 2, Recruiting

RCT of Mind-body in Long COVID and Myalgic Encephalomyelitis

for
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Location: Edmonton, Calgary
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT06933173

Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Sydney, Halifax, Bridgewater, Bangor ME, Scarborough ME,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase 3, Recruiting

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

for
Prostate Cancer (Adenocarcinoma)
Location: Saint John, Providence RI, Saint Johnsbury VT,
Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06592924

Phase 3, Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: New Haven CT, Quebec, New York NY, New Brunswick NJ,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase 3, Recruiting

Popular cities in Alberta

CalgaryEdmonton